Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Access to medicines and treatment news

Show

From To
When we find a cure, price it like Netflix to ensure access

An essential lesson from the successful fight against AIDS is that early access to effective treatment can avoid long-term costs. For hepatitis C treatment, Louisiana may have found a solution. The Department of Health is working on a new strategy to expand access—one that involves a licensing deal. The state would agree to pay a drug company for medication for several years in exchange for unlimited access to treatment.

Published
13 August 2018
From
The Hill
South Africa strikes deal on new TB drug as WHO revisits guidance

The World Health Organization could soon start promoting a new tuberculosis drug that is now more affordable after South Africa brokered a deal with a pharmaceutical company to slash the price by half.

Published
13 August 2018
From
Devex
Unable to Get Meds, Venezuelans With HIV Turn to Guásimo

An economic crisis is leading to desperation, DIY treatments and death.

Published
10 August 2018
From
Poz
Fast Track Cities Quality of Life Survey

We invite people living with HIV in 29 cities to complete a 10-minute online survey that will can assist us in better understanding the quality of life issues that impact urban AIDS responses. Your name will remain anonymous, but through your input you will have a positive effect on the quality of life of the global community of people living with HIV. The 29 cities include Amsterdam, Athens, Atlanta, Bamako, Bangkok, Berlin, Brussels, Bucharest, Buenos Aires, Dar es Salaam, Denver, Durban, Geneva, Kingston, Lisbon, Libreville, Madrid, Melbourne, Miami, Montréal, Nairobi, New Orleans, New York City, Oakland, Paris, Rio de Janeiro, Salvador de Bahia, San Francisco, and Santiago. UK Fast Track cities (Brighton and London) can fill it in by checking "other".

Published
09 August 2018
From
IAPAC
Price Of HIV Viral Load Test Falls, Raising Hopes In Global AIDS Fight

The Clinton Health Access Initiative, along with several other development agencies, has brokered an agreement to make routine HIV tests more accessible. They're aiming to make HIV viral load tests available for $12 a piece, slashing the price in some markets by more than 50 percent.

Published
02 August 2018
From
NPR
Game over for Gilead’s monopoly on Truvada

The judge of the Court of Justice of the European Union has just returned his verdict: the patent extension granted to Gilead on Truvada in many European countries is now illegal. AIDES has questioned the Intellectual Property misuses of the company for two years and welcomes this European ruling for three reasons: for healthcare systems users, for the sustainability of public budgets and for access to PrEP all over Europe.

Published
30 July 2018
From
AIDES
Terrence Higgins Trust launches Access Fund to support people who can’t afford HIV prevention drug PrEP

The fund will launch in the autumn and is intended to support up to 1,000 people in England and Northern Ireland.

Published
26 July 2018
From
Terrence Higgins Trust
UK HIV drugs bill may reduce following court ruling - implications for PrEP

A ruling today from the European Court of Justice (ECJ) suggests that Gilead’s patent for Truvada (the drug used to treat many people living with HIV, and the drug used for PrEP) may be under threat.

Published
25 July 2018
From
National AIDS Trust
Hologic's Global Access Initiative Increases Availability of Diagnostic Testing in Resource-Limited Countries

Hologic, Inc. announced today the launch of the new Hologic Global Access Initiative, in partnership with the Clinton Health Access Initiative (CHAI) and MedAccess (backed by the U.K. government), to increase affordable access to molecular testing for HIV, hepatitis B and C (HBV and HCV) and human papillomavirus (HPV) in nearly 50 nations around the world. These countries, primarily across Africa and Southeast Asia, make up 90 percent of the HIV disease burden globally.

Published
25 July 2018
From
Hologic press release
Pfizer and GSK's HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

Despite ViiV pledging in November 2017 that it would expedite the availability of paediatric dolutegravir formulations where these are most critically needed, and despite repeated appeals from MSF and others, almost 18 months after paediatric formulations of dolutegravir were approved for use by the European Medicines Agency, the corporation has started the registration process in only three sub-Saharan African countries

Published
23 July 2018
From
Médecins Sans Frontières (MSF) International
← First12345...122Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.